Glioblastoma Multiforme Research Related
People Related To Glioblastoma Multiforme Research
Assistant Professor, Basic Science Education, Virginia Tech Carilion School of Medicine
Research Assistant Professor, Biological Sciences, College of Science, Virginia Tech
Research Assistant Professor, Fralin Biomedical Research Institute at VTC
Assistant Professor, Fralin Biomedical Research Institute at VTC
Assistant Professor of Internal Medicine, Virginia Tech Carilion School of Medicine
Professor and Commonwealth Eminent Scholar in Cancer Research, Fralin Biomedical Research Institute at VTC
Director, Center for Glial Biology in Health, Disease, and Cancer
Executive Director, School of Neuroscience, College of Science, Virginia Tech
I. D. Wilson Chair in the College of Science, Virginia Tech
Events Related To Glioblastoma Multiforme
Stories Related To Glioblastoma Multiforme
Nov. 6, 2018
Scientists at the Virginia Tech Carilion Research Institute have solved a 125-year-old mystery of the brain, and, in the process, uncovered a potential treatment for acquired epilepsy. The research team ...
Sept. 11, 2018
Scientists with the Virginia Tech Carilion Research Institute say a gene involved in the body’s sleep cycle is a potential target for therapies to help patients with a deadly form ...
Jan. 25, 2018
A Virginia Tech Carilion Research Institute team has identified a new therapeutic target to treat glioblastoma, the most devastating and common form of brain cancer.
July 26, 2017
Research teams at the Virginia Tech Carilion Research Institute from three colleges — Engineering, Science, and Veterinary Medicine — are developing new approaches to treat glioblastoma, the aggressive form of ...
Nov. 16, 2015
Scientists from the Virginia Tech Carilion Research Institute and clinicians from Carilion Clinic have discovered how to sensitize drug-resistant human glioblastoma cells to chemotherapy.
April 9, 2015
Virginia Tech Carilion Research Institute scientists have developed new imaging techniques to watch dangerous brain tumor cells respond to treatment in real time.
Dec. 12, 2014
At the Virginia Tech Carilion Research Institute, three scientists are planning to create a virus capable of destroying brain cancer. It sounds like the stuff of science fiction, but it ...
Publications Related To Glioblastoma Multiforme
Pridham KJ, Varghese RT, Sheng Z. (2017). The Role of Class IA Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunits in Glioblastoma. Frontiers in Oncology 7(312).
Pridham KJ, Le L, Guo S, Varghese RT, Algino S, Liang Y, Fajardin R, Rodgers CM, Simonds GR, Kelly DF, Sheng Z. (2017). PIK3CB/p110β is a Selective Survival Factor for Glioblastoma. Neuro-Oncology.
Varghese RT, Lian Y, Guan T, Franck CT, Kelly DF, Sheng Z. (2016). Survival kinase genes present prognostic significance in glioblastoma. Oncotarget.
Murphy SF, Varghese RT, Lamouille S, Guo S, Pridham KJ, Kanabur P, Osimani AM, Sharma S, Jourdan J, Rodgers CM, Simonds GR, Gourdie RG, Sheng Z. (2016). Connexin 43 Inhibition Sensitizes Chemoresistant Glioblastoma Cells to Temozolomide. Cancer Research 76(1): 139-49.
Li T, Murphy S, Kiselev B, Bakshi KS, Zhang J, Eltahir A, Zhang Y, Chen Y, Zhu J, Davis RM, Madsen LA, Morris JR, Karolyi DR, LaConte SM, Sheng Z, Dorn HC. (2015). A New Interleukin-13 Amino-Coated Gadolinium Metallofullerene Nanoparticle for Targeted MRI Detection of Glioblastoma Tumor Cells. Journal of the American Chemical Society 137(24): 7881-8.
Pohlmann ES, Patel K, Guo S, Dukes MJ, Sheng Z, Kelly DF. (2015). Real-time visualization of nanoparticles interacting with glioblastoma stem cells. Nano Letters 15(4): 2329-35.